MX2024003870A - Produccion sintetica de vectores de adn circular. - Google Patents

Produccion sintetica de vectores de adn circular.

Info

Publication number
MX2024003870A
MX2024003870A MX2024003870A MX2024003870A MX2024003870A MX 2024003870 A MX2024003870 A MX 2024003870A MX 2024003870 A MX2024003870 A MX 2024003870A MX 2024003870 A MX2024003870 A MX 2024003870A MX 2024003870 A MX2024003870 A MX 2024003870A
Authority
MX
Mexico
Prior art keywords
circular dna
dna vectors
methods
synthetic production
pharmaceutical compositions
Prior art date
Application number
MX2024003870A
Other languages
English (en)
Spanish (es)
Inventor
Jose Lora
Jin Huh
Eileen Higham
Jodi Kennedy
Anne Maguire
Meisam Bakhshayesh
Eliza Dornbush
Original Assignee
Aldevron Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aldevron Llc filed Critical Aldevron Llc
Publication of MX2024003870A publication Critical patent/MX2024003870A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/64—General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX2024003870A 2021-09-27 2022-09-27 Produccion sintetica de vectores de adn circular. MX2024003870A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163248801P 2021-09-27 2021-09-27
PCT/US2022/077108 WO2023049937A2 (en) 2021-09-27 2022-09-27 Synthetic production of circular dna vectors

Publications (1)

Publication Number Publication Date
MX2024003870A true MX2024003870A (es) 2024-09-11

Family

ID=85721330

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2024003870A MX2024003870A (es) 2021-09-27 2022-09-27 Produccion sintetica de vectores de adn circular.

Country Status (10)

Country Link
US (1) US20240409975A1 (enExample)
EP (1) EP4408994A4 (enExample)
JP (1) JP2024535917A (enExample)
KR (1) KR20240126447A (enExample)
CN (1) CN118679248A (enExample)
AU (1) AU2022349697A1 (enExample)
CA (1) CA3233230A1 (enExample)
IL (1) IL311778A (enExample)
MX (1) MX2024003870A (enExample)
WO (1) WO2023049937A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2026515898A (ja) * 2023-04-28 2026-05-19 ユニバーシティ オブ メリーランド、バルティモア カウンティ インビトロでスーパーコイル状の環状dnaを作製する方法
WO2025007021A2 (en) * 2023-06-30 2025-01-02 Novel Biotechnology Inc. Cell-free replication of a nucleic acid construct
WO2025175112A1 (en) * 2024-02-16 2025-08-21 University Of Maryland, Baltimore County Method for generating circular dna using heteroduplex thermostable ligation assembly of precursors produced by rolling circle amplification

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE340264T1 (de) * 2003-06-10 2006-10-15 Mologen Ag Zirkuläres expressionskonstrukt für gentherapeutische anwendungen
WO2006063355A2 (en) * 2004-12-11 2006-06-15 Cytogenix , Inc. Cell free biosynthesis of high-quality nucleic acid and uses thereof
US8153598B2 (en) * 2005-10-19 2012-04-10 Intrexon Corporation PKD ligands and polynucleotides encoding PKD ligands
GB201321123D0 (en) * 2013-11-29 2014-01-15 Linea Ab Q Amplification of circular molecules
JP7058502B2 (ja) * 2014-04-11 2022-04-22 レッドボールト バイオサイエンシズ エルピー ゲノム適用および治療適用のための、核酸分子のクローン複製および増幅のためのシステムおよび方法
FR3032447B1 (fr) * 2015-02-10 2020-02-21 Universite Des Sciences Et Technologies De Lille-Lille 1 Procede de fabrication de vecteurs d'adn a partir de briques moleculaires contenant des sequences d'interet
JP7335224B2 (ja) * 2017-07-18 2023-08-29 ジェノヴィー エービー 全長t細胞受容体オープンリーディングフレームの迅速な組立ておよび多様化のための二成分ベクターライブラリシステム
EP3987043A4 (en) * 2019-06-21 2023-07-19 Asklepios Biopharmaceutical, Inc. PRODUCTION OF VECTORS USING THE PHAGEN REPLICATION ORIGIN
WO2021055760A1 (en) * 2019-09-18 2021-03-25 Intergalactic Therapeutics, Inc. Synthetic dna vectors and methods of use

Also Published As

Publication number Publication date
US20240409975A1 (en) 2024-12-12
CA3233230A1 (en) 2023-03-30
JP2024535917A (ja) 2024-10-02
WO2023049937A3 (en) 2023-08-10
IL311778A (en) 2024-05-01
CN118679248A (zh) 2024-09-20
AU2022349697A1 (en) 2024-05-16
KR20240126447A (ko) 2024-08-20
WO2023049937A2 (en) 2023-03-30
EP4408994A4 (en) 2025-04-09
EP4408994A2 (en) 2024-08-07

Similar Documents

Publication Publication Date Title
WO2023049937A3 (en) Synthetic production of circular dna vectors
EP2102337A4 (en) MICROORGANISM OF THE GENUS CORYNEBACTERIUM WITH REINFORCED L-LYSINE PRODUCTIVITY AND METHOD FOR THE PRODUCTION OF L-LYSINE THEREWITH
DE60323340D1 (de) Verfahren zur herstellung interferierender rna-moleküle in säugetierzellen und therapeutische anwendungen solcher moleküle
EP4086355A3 (en) A genus of epimerase enzymes for conversion of fructose to allulose at high temperature and low ph
CY1118222T1 (el) Συνθεσεις λυασης φαινυλαλανινης αμμωνιας προκαρυωτικων και μεθοδοι αγωγης καρκινου χρησιμοποιωντας συνθεσεις εξ' αυτης
MX2022003091A (es) Retroelemento bacteriano modificado con produccion de adn mejorada.
DK1945762T3 (da) Rationelt konstruerede meganucleaser med ændret sekvensspecificitet og DNA-bindingsaffinitet
EA202190889A1 (ru) Клостридиальные нейротоксины, содержащие экзогенную петлю активации
YU83101A (sh) Postupci i materijali za sinteze organskih proizvoda
MX2021004035A (es) Producción enzimática de tagatosa.
CY1109471T1 (el) Μεθοδοι και μεσα για την παραγωγη υαλουρονανης
DK1940348T3 (da) Sammensætning omfattende et koblet enzymsystem
MY161185A (en) Novel microbial succinic acid producers and purification of succinic acid
EP4483718A3 (en) Proteolytically stable u1-agatoxin-ta1b variant polypeptides for pest control
ZA202207168B (en) Therapeutic double stranded rna and methods for producing the same
ZA202212862B (en) Method for the continuous synthesis of paracetamol
WO2023114936A3 (en) Subtilisin variants and methods of use
PH12012501172A1 (en) Process for production of optically active amine derivatives
Cheng et al. A switch in a substrate tunnel for directing regioselectivity of nitrile hydratases towards α, ω-dinitriles
WO2023108107A3 (en) Modified immune cells and methods of using the same
MY170467A (en) High molecular weight pha-producing microbe and method of producing high molecular weight pha using same
EA201992527A1 (ru) Улучшенный способ крупномасштабного производства crm
BRPI0516946A (pt) enzimas lacase e seus usos
MX348766B (es) Metodo de expresion.
MX2025014624A (es) Metodos para producir betalaina modificadas en levadura